Your browser doesn't support javascript.
loading
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory.
Moulder, Robert; Välikangas, Tommi; Hirvonen, M Karoliina; Suomi, Tomi; Brorsson, Caroline A; Lietzén, Niina; Bruggraber, Sylvaine F A; Overbergh, Lut; Dunger, David B; Peakman, Mark; Chmura, Piotr J; Brunak, Soren; Schulte, Anke M; Mathieu, Chantal; Knip, Mikael; Elo, Laura L; Lahesmaa, Riitta.
Affiliation
  • Moulder R; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • Välikangas T; InFLAMES Research Flagship Center, University of Turku, Turku, Finland.
  • Hirvonen MK; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • Suomi T; InFLAMES Research Flagship Center, University of Turku, Turku, Finland.
  • Brorsson CA; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • Lietzén N; InFLAMES Research Flagship Center, University of Turku, Turku, Finland.
  • Bruggraber SFA; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • Overbergh L; InFLAMES Research Flagship Center, University of Turku, Turku, Finland.
  • Dunger DB; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Peakman M; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • Chmura PJ; Department of Paediatrics, University of Cambridge, Cambridge, UK.
  • Brunak S; Katholieke Universiteit Leuven/Universitaire Ziekenhuizen, Leuven, Belgium.
  • Schulte AM; Department of Paediatrics, University of Cambridge, Cambridge, UK.
  • Mathieu C; Immunology & Inflammation Research Therapeutic Area, Sanofi, Boston, MA, USA.
  • Knip M; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Elo LL; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Lahesmaa R; Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany.
Diabetologia ; 66(11): 1983-1996, 2023 11.
Article in En | MEDLINE | ID: mdl-37537394
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 Type of study: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adolescent / Humans Language: En Journal: Diabetologia Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 Type of study: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adolescent / Humans Language: En Journal: Diabetologia Year: 2023 Document type: Article Affiliation country: Country of publication: